Search by Drug Name or NDC

NDC 51655-0144-26 Ramipril 5 mg/1 Details

Ramipril 5 mg/1

Ramipril is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals, LLC. The primary component is RAMIPRIL.

MedlinePlus Drug Summary

Ramipril is used alone or in combination with other medications to treat high blood pressure. It is also used to reduce the risk of heart attack and stroke in patients at risk for these problems and to improve survival in patients with heart failure after a heart attack. Ramipril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly and the heart can pump blood more efficiently. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Related Packages: 51655-0144-26
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ramipril

Product Information

NDC	51655-0144
Product ID	51655-144_088d0db2-371c-d404-e063-6394a90a360f
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Ramipril
Proprietary Name Suffix	n/a
Non-Proprietary Name	Ramipril
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	5
Active Ingredient Units	mg/1
Substance Name	RAMIPRIL
Labeler Name	Northwind Pharmaceuticals, LLC
Pharmaceutical Class	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA077626
Listing Certified Through	2024-12-31

Package

NDC 51655-0144-26 (51655014426)

Pricing Information	N/A
NDC Package Code	51655-144-26
Billing NDC	51655014426
Package	90 CAPSULE in 1 BOTTLE, PLASTIC (51655-144-26)
Marketing Start Date	2020-05-27
NDC Exclude Flag	N